Clinical Trial NCT06933914

Trial

Wuhan MY008211A-PNH-2-03 (NCT06933914)

Clinical trial ID

NCT06933914

Drug name

MY008211A tablets

Company:

Wuhan Createrna Science and Technology Co., Ltd

Drug trade name

Clinicaltrials.gov

Learn more

Phase of study

2, 3

Current status

Recruiting

Start

11/2024

Substance

Research question

To assess the long‑term safety and tolerability of MY008211A tablets in adult patients with paroxysmal nocturnal hemoglobinuria (PNH)

Delivery method of drug

Frequency

Clinical trial locations

China